Outcome of Patients Undergoing Leadless Pacemaker Implantaton
Launched by AZIENDA OSPEDALIERA CARDINALE G. PANICO · Oct 22, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Observational, multicenter study enrolling consecutive patients undergoing leadless pacemaker implantation. Procedure details, intraprocedural complications, and n-hospital outcomes will be recorded.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients with indication for leadless pacemaker implantation according to current Guidelines on cardiac pacing.
- Exclusion Criteria:
- • inability to sign informed consent
About Azienda Ospedaliera Cardinale G. Panico
Azienda Ospedaliera Cardinale G. Panico is a distinguished healthcare institution based in Italy, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong commitment to excellence in patient care and a multidisciplinary approach, the hospital collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical studies across various therapeutic areas. By integrating cutting-edge technology and evidence-based practices, Azienda Ospedaliera Cardinale G. Panico aims to contribute significantly to the development of new treatments and enhance the overall quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tricase, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported